The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...
The Department of Health and Human Services (HHS) is reportedly poised to slash funding for domestic HIV prevention at the Centers for Disease Control and Prevention (CDC), The Wall Street Journal ...
Hosted on MSN
CDC cuts hit HIV prevention program, jeopardizing decades of progress on reducing infant transmission rates
Public health, explained: Sign up to receive Healthbeat’s free Atlanta newsletter here. The sharp job cuts at the Centers for Disease Control and Prevention include a successful program reducing HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results